DCF — MARTIN MEDICAL CENTER
Enterprise Value: $-169.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-169.3M
Enterprise Value
$-71.9M
PV of Cash Flows
$-97.5M
PV of Terminal Value
$-157.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $686.4M | $0.5M | 0.0% | $-28.5M | $-25.9M |
| Year 2 | $707.0M | $7.6M | 1.0% | $-22.3M | $-18.4M |
| Year 3 | $728.2M | $15.1M | 2.0% | $-15.7M | $-11.8M |
| Year 4 | $750.1M | $19.3M | 3.0% | $-12.6M | $-8.6M |
| Year 5 | $772.6M | $21.9M | 3.0% | $-11.5M | $-7.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-169.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$666.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0042177065801178755
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5